Asheville, N.C. — While emphasizing that the company has received no reports of illness or injury, King Bio expanded its voluntary product recall to include all aqueous-based products for human and animal use due to possible microbial contamination. Distributors and retail customers are being notified by letter to make arrangements...
This article was updated on Aug. 24 to reflect new dates for the recalled products (which had been wrong on the FDA website) and to incorporate a statement from Dr. Frank King. Asheville, NC — "Out of an abundance of caution," King Bio issued a voluntary nationwide consumer recall of...
The Food and Drug Administration (FDA) has extended the public comment period for its Draft Guidance ruling on homeopathic drugs for 60 days, bringing the deadline to May 21, 2018. There are several ways to submit comments. The FDA is accepting electronic comments here, or written comments to an address...
This past November, 46% of American adults awoke one morning to find they had high blood pressure (aka hypertension). In men under age 45, the increase was most startling—hypertension prevalence tripled! What caused this tremendous jump in blood pressure issues? Hint: It wasn't some catastrophic and widespread public health event.
As the deadline draws near for the U.S. Food and Drug Administration's (FDA) decision on how to regulate homeopathic remedies, and an article in the mainstream media reignites the issue, homeopathic agencies and experts are offering guidance to those awaiting the decision. As we reported back in December, the FDA...
The U.S. Food and Drug Admininstration (FDA) has proposed a new risk-based enforcement approach to drugs labeled as homeopathic. Many homeopathic treatments are being marketed as remedies for serious diseases and conditions when there is no actual proof the products provide clinical benefits, FDA says. Certain homeopathic-labeled products do not...
